Company profile
CombiGene company profile
CombiGene provides patients affected by severe life-altering diseases with the prospect of a better life through novel gene therapies. CombiGene’s business concept is to develop effective gene therapies for severe life-altering diseases where adequate treatment is currently lacking. CombiGene is developing a breakthrough therapy with the potential to dramatically improve the quality of life for a group of epilepsy patients for whom there is currently no effective treatment. CombiGene uses an adeno-associated viral vector (AAV) to administer a combination of neuropeptide Y (NPY) and its receptor Y2 directly to the part of the brain where the epileptic seizure begins. The..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- http://combigene.com/
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $0+
- Founded
- 2008-01-01
Headquarters
- Headquarters
- Lund, Skane Lan, Sweden
- Postal code
- 223 81
- Country code
- SE
- Continent
- Europe